<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Biotechnology Law Report via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Biotechnology Law Report' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Biotechnology+Law+Report&t=Biotechnology+Law+Report&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 21 Mar 2010 15:23:12 +0100</lastBuildDate>
        <item>
            <title>Competition Law and Access to Pharmaceutical Technology in the Developing World</title>
            <link>http://www.medworm.com/index.php?rid=3380807&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9888%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 693-715. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380807</comments>
            <pubDate>Fri, 19 Mar 2010 03:02:22 +0100</pubDate>
            <guid isPermaLink="false">3380807</guid>        </item>
        <item>
            <title>Bibliography</title>
            <link>http://www.medworm.com/index.php?rid=3380816&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9879%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 737-737. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380816</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:11 +0100</pubDate>
            <guid isPermaLink="false">3380816</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=3380826&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9877%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 827-828. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380826</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:10 +0100</pubDate>
            <guid isPermaLink="false">3380826</guid>        </item>
        <item>
            <title>On The Move</title>
            <link>http://www.medworm.com/index.php?rid=3380817&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9878%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 739-740. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380817</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:10 +0100</pubDate>
            <guid isPermaLink="false">3380817</guid>        </item>
        <item>
            <title>Former InterMune CEO Convicted of Wire Fraud; Further Troubles for Sequenom: Investigations, Shareholder Lawsuit Follow Alleged Mishandling of Data on Fetal Test; Amgen Sued over Aranesp Sales Practices; ZymoGenetics Can Resume Marketing Campaign; Congressional Members Request Drug Price Inquiries; Steps Forward in Decode Bankruptcy Case</title>
            <link>http://www.medworm.com/index.php?rid=3380813&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9882%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 729-731. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380813</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:09 +0100</pubDate>
            <guid isPermaLink="false">3380813</guid>        </item>
        <item>
            <title>Stanford Does Not Own HIV Load Patent; Gen-Probe, Becton Dickinson in Suit over Diagnostics; Eppendorf Sues Nanosphere on Microarray Technology; Other Items of Interest: You Have to Cooperate with the PTO; Malpractice Suit in Patent Case Reinstated</title>
            <link>http://www.medworm.com/index.php?rid=3380812&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9883%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 727-728. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380812</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:09 +0100</pubDate>
            <guid isPermaLink="false">3380812</guid>        </item>
        <item>
            <title>ORI Finds Misconduct in Work on Brain Tumor Treatment; Papers on Glycosylation Technique Withdrawn; Falsified Images and Data Manipulation, But Conclusions Stand; Protein Structures May Have Been Fabricated</title>
            <link>http://www.medworm.com/index.php?rid=3380815&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9880%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 735-736. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380815</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:08 +0100</pubDate>
            <guid isPermaLink="false">3380815</guid>        </item>
        <item>
            <title>Suit over Knock-In Technology Dismissed by French Court</title>
            <link>http://www.medworm.com/index.php?rid=3380814&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9881%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 733-733. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380814</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:07 +0100</pubDate>
            <guid isPermaLink="false">3380814</guid>        </item>
        <item>
            <title>PhRMA Releases Trial Guidelines; New Guidance on Protection for Trial Subjects; Trial of Embryonic Stem Cells May Resume; EU Clinical Trial Rules Criticized; Penalties for Not Protecting Subject Data</title>
            <link>http://www.medworm.com/index.php?rid=3380809&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9886%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 719-720. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380809</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:07 +0100</pubDate>
            <guid isPermaLink="false">3380809</guid>        </item>
        <item>
            <title>Critical Drug Information Not Reaching Prescribers; Guidance for REMS; Stem Cell Trial for ALS Scheduled; Orphan Drug Status for a Gene Therapy; Safe Use Initiative from FDA; Antigenics Withdraws European Oncophage Application</title>
            <link>http://www.medworm.com/index.php?rid=3380808&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9887%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 717-718. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380808</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:06 +0100</pubDate>
            <guid isPermaLink="false">3380808</guid>        </item>
        <item>
            <title>So Is There a Written Description Requirement? Two Amicus Briefs in Ariad Make Opposite Arguments; Limits on Claims and Continuations Cancelled—For Now; Human Embryonic Stem Cell Case Sent to European Court of Justice; Europe Acts against “Pay to Delay” Settlements</title>
            <link>http://www.medworm.com/index.php?rid=3380811&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9884%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 723-725. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380811</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:05 +0100</pubDate>
            <guid isPermaLink="false">3380811</guid>        </item>
        <item>
            <title>Touchcom, Inc. and Touchcom Technologies, Inc. v. Bereskin &amp; Parr and H. Samuel Frost [excerpts]</title>
            <link>http://www.medworm.com/index.php?rid=3380825&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9889%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 819-825. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380825</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:04 +0100</pubDate>
            <guid isPermaLink="false">3380825</guid>        </item>
        <item>
            <title>Clearance of Sugar Beets Put on Hold; High-Omega 3 Soybean Oil Called GRAS; Monsanto Asks for Supreme Court Review of Alfalfa Case</title>
            <link>http://www.medworm.com/index.php?rid=3380810&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9885%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 721-721. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380810</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:04 +0100</pubDate>
            <guid isPermaLink="false">3380810</guid>        </item>
        <item>
            <title>Gilbert P. Hyatt v. John J. Doll [excerpts]</title>
            <link>http://www.medworm.com/index.php?rid=3380823&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9891%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 797-808. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380823</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:02 +0100</pubDate>
            <guid isPermaLink="false">3380823</guid>        </item>
        <item>
            <title>Patent Application Backlog Reduction Stimulus Plan</title>
            <link>http://www.medworm.com/index.php?rid=3380822&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9892%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 795-796. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380822</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:01 +0100</pubDate>
            <guid isPermaLink="false">3380822</guid>        </item>
        <item>
            <title>Brief of Washington Legal Foundation as Amicus Curiae in Support of Defendant-Appellant Supporting Reversal: Ariad Pharmaceuticals, Inc. et al. v. Eli Lilly and Company</title>
            <link>http://www.medworm.com/index.php?rid=3380821&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9893%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 785-794. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380821</comments>
            <pubDate>Fri, 19 Mar 2010 00:21:00 +0100</pubDate>
            <guid isPermaLink="false">3380821</guid>        </item>
        <item>
            <title>Brief of Christopher M. Holman as Amicus Curiae in Support of Neither Party: Ariad Pharmaceuticals, Inc. et al. v. Eli Lilly and Company</title>
            <link>http://www.medworm.com/index.php?rid=3380820&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9894%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 775-784. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380820</comments>
            <pubDate>Fri, 19 Mar 2010 00:20:59 +0100</pubDate>
            <guid isPermaLink="false">3380820</guid>        </item>
        <item>
            <title>Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications—Guidance for Industry</title>
            <link>http://www.medworm.com/index.php?rid=3380819&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9895%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 755-773. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380819</comments>
            <pubDate>Fri, 19 Mar 2010 00:20:59 +0100</pubDate>
            <guid isPermaLink="false">3380819</guid>        </item>
        <item>
            <title>FDA's Safe Use Initiative: Collaborating to Reduce Preventable Harm from Medications—Guidance for Industry</title>
            <link>http://www.medworm.com/index.php?rid=3380818&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9896%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 741-753. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380818</comments>
            <pubDate>Fri, 19 Mar 2010 00:20:58 +0100</pubDate>
            <guid isPermaLink="false">3380818</guid>        </item>
        <item>
            <title>Board of Trustees of the Leland Stanford Junior University and Thomas Merigan and Mark Holodniy v. Roche Molecular Systems, Inc. et al</title>
            <link>http://www.medworm.com/index.php?rid=3380824&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9890%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2009, Vol. 28, No. 6: 809-817. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3380824</comments>
            <pubDate>Fri, 19 Mar 2010 00:20:54 +0100</pubDate>
            <guid isPermaLink="false">3380824</guid>        </item>
        <item>
            <title>Antipromethean Fallacies: A Critique of Fukuyama's Bioethics</title>
            <link>http://www.medworm.com/index.php?rid=3077437&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9915%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 577-590. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077437</comments>
            <pubDate>Thu, 10 Dec 2009 20:58:02 +0100</pubDate>
            <guid isPermaLink="false">3077437</guid>        </item>
        <item>
            <title>Prometheus Laboratories, Inc. v. Mayo Collaborative Services and Mayo Clinic Rochester</title>
            <link>http://www.medworm.com/index.php?rid=3077456&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9911%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 681-689. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077456</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:36 +0100</pubDate>
            <guid isPermaLink="false">3077456</guid>        </item>
        <item>
            <title>Some Thoughts</title>
            <link>http://www.medworm.com/index.php?rid=3077438&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9910%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 591-591. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077438</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:35 +0100</pubDate>
            <guid isPermaLink="false">3077438</guid>        </item>
        <item>
            <title>Amgen Inc. v. F. Hoffmann-La Roche Ltd., Roche Diagnostics GMBH, and Hoffmann-La Roche Inc</title>
            <link>http://www.medworm.com/index.php?rid=3077452&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9913%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 634-663. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077452</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:34 +0100</pubDate>
            <guid isPermaLink="false">3077452</guid>        </item>
        <item>
            <title>AsymmetRx, Inc. v. Biocare Medical, LLC</title>
            <link>http://www.medworm.com/index.php?rid=3077453&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9912%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 664-668. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077453</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:33 +0100</pubDate>
            <guid isPermaLink="false">3077453</guid>        </item>
        <item>
            <title>Martek Biosciences Corp. v. Nutrinova, Inc. et al</title>
            <link>http://www.medworm.com/index.php?rid=3077450&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9914%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 615-627. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077450</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:32 +0100</pubDate>
            <guid isPermaLink="false">3077450</guid>        </item>
        <item>
            <title>Guidance for Industry Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting</title>
            <link>http://www.medworm.com/index.php?rid=3077451&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9935%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 628-633. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077451</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:31 +0100</pubDate>
            <guid isPermaLink="false">3077451</guid>        </item>
        <item>
            <title>Mistrial Declared in Fosamax Case</title>
            <link>http://www.medworm.com/index.php?rid=3077442&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9906%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 598-598. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077442</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:30 +0100</pubDate>
            <guid isPermaLink="false">3077442</guid>        </item>
        <item>
            <title>BIO More Interested in Patents Than Embryonic Stem Cells; Stem Cell Therapeutics Receives Indian Patents on Neural Stem Cells; Neuralstem Wins U.S. Patent on Neural Stem Cell Transplantation; Legal OnRamp Files Amicus Brief in Bilski</title>
            <link>http://www.medworm.com/index.php?rid=3077443&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9905%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 599-600. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077443</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:29 +0100</pubDate>
            <guid isPermaLink="false">3077443</guid>        </item>
        <item>
            <title>Delayed-Metabolism EPO Still Cannot Be Imported; Diagnostic and Treatment Methods Are Patentable</title>
            <link>http://www.medworm.com/index.php?rid=3077444&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9904%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 601-607. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077444</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:28 +0100</pubDate>
            <guid isPermaLink="false">3077444</guid>        </item>
        <item>
            <title>Medicare Taking Close Look at Erythropoietin Coverage; Elan-Biogen Deal for Tysabri Violated</title>
            <link>http://www.medworm.com/index.php?rid=3077445&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9903%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 608-608. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077445</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:27 +0100</pubDate>
            <guid isPermaLink="false">3077445</guid>        </item>
        <item>
            <title>NSF to Require Ethics Training; Celgene Accused of Misappropriating Product Idea; Paper on Epilepsy Origin Withdrawn</title>
            <link>http://www.medworm.com/index.php?rid=3077446&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9902%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 609-610. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077446</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:26 +0100</pubDate>
            <guid isPermaLink="false">3077446</guid>        </item>
        <item>
            <title>Bibliography</title>
            <link>http://www.medworm.com/index.php?rid=3077448&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9899%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 613-613. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077448</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:25 +0100</pubDate>
            <guid isPermaLink="false">3077448</guid>        </item>
        <item>
            <title>Restrictions on Nonhuman Primate Research; Genetic Ancestry Testing Needs Tighter Controls; Revisions Coming in Regulation of Potential Biowarfare Agents</title>
            <link>http://www.medworm.com/index.php?rid=3077447&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9901%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 611-612. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077447</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:25 +0100</pubDate>
            <guid isPermaLink="false">3077447</guid>        </item>
        <item>
            <title>Ortho-McNeil Pharmaceutical, Inc. and Johnson &amp; Johnson Pharmaceutical Research and Development, LLC et al. v. Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc</title>
            <link>http://www.medworm.com/index.php?rid=3077455&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9929%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 677-680. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077455</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:24 +0100</pubDate>
            <guid isPermaLink="false">3077455</guid>        </item>
        <item>
            <title>Clinical Trial Registries Failing</title>
            <link>http://www.medworm.com/index.php?rid=3077440&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9908%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 596-596. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077440</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:22 +0100</pubDate>
            <guid isPermaLink="false">3077440</guid>        </item>
        <item>
            <title>Guidance for Anticounterfeiting Measures; Crackdown on Rogue Investigators; Better Access to Experimental Drugs; Federal Law May Not Be Needed to Regulate DTC Genetic Tests; Newspaper Sued over Story on Drug Manufacturer; Postmarketing Adverse Events Must Be Reported Electronically; Genzyme Plant Problems Causing FDA to Ease Restrictions on Experimental Drug Access; Pfizer Fined Again for Off-Label Promotion; Postmarketing Studies Being Performed as Ordered; FDA Warning Letters to Be Easier to View; Experimental Diabetes Drug to Become More Readily Available</title>
            <link>http://www.medworm.com/index.php?rid=3077439&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9909%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 592-595. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077439</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:22 +0100</pubDate>
            <guid isPermaLink="false">3077439</guid>        </item>
        <item>
            <title>Further Details on Biotechnology Quality Management System</title>
            <link>http://www.medworm.com/index.php?rid=3077441&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9907%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 597-597. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077441</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:21 +0100</pubDate>
            <guid isPermaLink="false">3077441</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=3077457&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9897%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 690-692. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077457</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:20 +0100</pubDate>
            <guid isPermaLink="false">3077457</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=3077449&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9898%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 614-614. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077449</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:19 +0100</pubDate>
            <guid isPermaLink="false">3077449</guid>        </item>
        <item>
            <title>Altana Pharma AG and Wyeth v. Teva Pharmaceuticals USA, Inc. et al</title>
            <link>http://www.medworm.com/index.php?rid=3077454&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9930%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2009, Vol. 28, No. 5: 669-676. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077454</comments>
            <pubDate>Thu, 10 Dec 2009 20:47:16 +0100</pubDate>
            <guid isPermaLink="false">3077454</guid>        </item>
        <item>
            <title>Japanese Biotech Patenting Strategies in the Era of Follow-On Biologics</title>
            <link>http://www.medworm.com/index.php?rid=2945493&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9928%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 483-496. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945493</comments>
            <pubDate>Fri, 30 Oct 2009 17:07:55 +0100</pubDate>
            <guid isPermaLink="false">2945493</guid>        </item>
        <item>
            <title>Bibliography</title>
            <link>http://www.medworm.com/index.php?rid=2945504&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9917%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 529-530. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945504</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:18 +0100</pubDate>
            <guid isPermaLink="false">2945504</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=2945505&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9916%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 531-531. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945505</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:17 +0100</pubDate>
            <guid isPermaLink="false">2945505</guid>        </item>
        <item>
            <title>Vermont Requires Full Disclosure of Payments to Healthcare Providers; Medicare Panel Wants Pathway for Follow-On Biologics; Sequenom Being Investigated by SEC over Down's Syndrome Test Problems; Amgen Pays Fine for Allegedly Overcharging</title>
            <link>http://www.medworm.com/index.php?rid=2945502&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9919%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 524-524. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945502</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:16 +0100</pubDate>
            <guid isPermaLink="false">2945502</guid>        </item>
        <item>
            <title>Two Researchers Barred from Involvement in Clinical Trials; Enough, Already! The Scientist Says Some Who Are Guilty of Misconduct; Deserve a Second Chance; The Non-Expert Expert?; More Questions About Payments to Surgeon Researcher; Fake Paper Creates Questions About “Open Access” Journals; Elsevier Said to Have Published Eight Additional Journals with Undisclosed Drug Company Sponsorship; Transplantation Researchers Have 8-Year History of Fraud, ORI Says</title>
            <link>http://www.medworm.com/index.php?rid=2961174&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9918%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 525-528. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2961174</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:15 +0100</pubDate>
            <guid isPermaLink="false">2961174</guid>        </item>
        <item>
            <title>Two Researchers Barred from Involvement in Clinical Trials; Enough, Already! The Scientist Says Some Who Are Guilty of Misconduct; Deserve a Second Chance; The Non-Expert Expert?; More Questions About Payments to Surgeon Researcher; Fake Paper Creates Questions About “Open Access” Journals; Elsevier Said to Have Published Eight Additional Journals with Undisclosed; Drug Company Sponsorship Transplantation Researchers Have 8-Year History of Fraud, ORI Says</title>
            <link>http://www.medworm.com/index.php?rid=2945503&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9918%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 525-528. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945503</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:15 +0100</pubDate>
            <guid isPermaLink="false">2945503</guid>        </item>
        <item>
            <title>Guidance for Industry: Presenting Risk Information in Prescription Drug and Medical Device Promotion</title>
            <link>http://www.medworm.com/index.php?rid=2945507&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9936%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 537-554. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945507</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:14 +0100</pubDate>
            <guid isPermaLink="false">2945507</guid>        </item>
        <item>
            <title>Takeda Pharmaceutical Co., Ltd. v. John J. Doll, Acting Under Secretary of Commerce for Intellectual Property</title>
            <link>http://www.medworm.com/index.php?rid=2945508&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9932%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 555-561. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945508</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:13 +0100</pubDate>
            <guid isPermaLink="false">2945508</guid>        </item>
        <item>
            <title>Guidance for Industry: Integrated Summaries of Effectiveness and Safety: Location Within the Common Technical Document</title>
            <link>http://www.medworm.com/index.php?rid=2945506&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9937%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 532-536. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945506</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:13 +0100</pubDate>
            <guid isPermaLink="false">2945506</guid>        </item>
        <item>
            <title>Double Patenting and Process Patents; Apparently, Oxford, U.K., Is Not in California; When Does the Two-Way Test for Obviousness Apply?; Illumina Sues for Infringement of Analytical Technology Patent; Ruling in Favor of Affymetrix Overturned; Abbott Ordered to Pay $1.67 Billion; BASF Sues Pioneer Hi-Bred for Unlawful Use of Technology; DuPont Countersues Monsanto; Beckman, Orchid, and Sequenom Suit Dropped</title>
            <link>http://www.medworm.com/index.php?rid=2945501&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9920%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 517-523. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945501</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:12 +0100</pubDate>
            <guid isPermaLink="false">2945501</guid>        </item>
        <item>
            <title>In re Frits Jacobus Fallaux, Robert Cornelius Hoeben, Alex Jan van der Eb, Abraham Bout, and Domenico Valerio</title>
            <link>http://www.medworm.com/index.php?rid=2945510&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9933%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 573-576. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945510</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:11 +0100</pubDate>
            <guid isPermaLink="false">2945510</guid>        </item>
        <item>
            <title>FDA Cannot Write Definitions on Its Own; APHIS Releases Biotechnology Quality Management System; Environmental Impact Statement Needed for Alfalfa; EU Finds Monsanto Corn Safe; High-Oleic Soybeans Okayed; Farmer Irritated with Biotechnology Opponents; Canada Drops Canola Complaint Against WTO; Cambridge to Ban Level 4 Laboratories; Restriction on Use of Antibiotics in Animal Field; Eight-Feature Corn Gets U.S., Canadian Approval</title>
            <link>http://www.medworm.com/index.php?rid=2945498&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9923%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 509-511. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945498</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:10 +0100</pubDate>
            <guid isPermaLink="false">2945498</guid>        </item>
        <item>
            <title>Cardiac Stem Cell Trial to Proceed; Earlier Use of Drugs That Have Completed Clinical Trials; Harmonization of European Clinical Trial Rules Demanded</title>
            <link>http://www.medworm.com/index.php?rid=2945497&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9924%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 508-508. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945497</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:10 +0100</pubDate>
            <guid isPermaLink="false">2945497</guid>        </item>
        <item>
            <title>Steps Taken to Prevent Federal Preemption; CAFC Finds Vaccine Did Cause Child's Injury</title>
            <link>http://www.medworm.com/index.php?rid=2945499&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9922%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 512-513. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945499</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:09 +0100</pubDate>
            <guid isPermaLink="false">2945499</guid>        </item>
        <item>
            <title>ACLU, Others Attack Patents on Breast Cancer Genes; PTO Upholds Patents on Uses of Stem Cells; Venture Capital Group Says 12 Years of Exclusivity Required for Biologics; DoJ Objects to Pay-to-Delay Agreements; EU Acts on Pay-to-Delay Issue; U.K. Minister Asks for Surrender of Patent Rights to Anti-HIV Drugs</title>
            <link>http://www.medworm.com/index.php?rid=2945500&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9921%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 514-516. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945500</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:08 +0100</pubDate>
            <guid isPermaLink="false">2945500</guid>        </item>
        <item>
            <title>Comment on Getting Written Description Right in the Biotechnology Arts: A Realist Approach to Patent Scope</title>
            <link>http://www.medworm.com/index.php?rid=2945494&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9927%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 497-499. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945494</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:04 +0100</pubDate>
            <guid isPermaLink="false">2945494</guid>        </item>
        <item>
            <title>Personalized Medicine: Planning for the Future Colloquium I: Diagnostics and Diagnoses, Paths to Personalized Medicine</title>
            <link>http://www.medworm.com/index.php?rid=2945495&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9926%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 500-502. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945495</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:03 +0100</pubDate>
            <guid isPermaLink="false">2945495</guid>        </item>
        <item>
            <title>Guidance on Placement of Integrated Effectiveness and Safety Summaries; Advice from FDA on Presenting Risk Information; More Warnings for Erlotinib; Sanofi-Aventis Said to Overstate Efficacy of Docetaxel; Possible Dosage Alterations for Rituximab; FDA Establishes Transparency Task Force; Unauthorized Clinical Trials Alleged; FDA Should Release Information on Unapproved Uses; Pegylated Anti-TNF Product Closer to European Approval; Viral Contaminant Reducing Supplies of Replacement Enzymes; First Follow-On Biologic Approved in Japan; More Human Embryonic Stem Cell Lines May Be Approved for Research; All Genetic Tests and Performance Data Should Be Registered; Early Development of Biologics to Gain New Regulatory Body in India; Rapid Test for C. diff. Approved; Label Changes for Immunosuppressives Reflect Concern About Kidney Virus</title>
            <link>http://www.medworm.com/index.php?rid=2945496&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9925%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 503-507. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945496</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:02 +0100</pubDate>
            <guid isPermaLink="false">2945496</guid>        </item>
        <item>
            <title>Autogenomics, Inc. v. Oxford Gene Technology Limited</title>
            <link>http://www.medworm.com/index.php?rid=2945509&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9931%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Aug 2009, Vol. 28, No. 4: 562-572. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2945509</comments>
            <pubDate>Fri, 30 Oct 2009 16:56:00 +0100</pubDate>
            <guid isPermaLink="false">2945509</guid>        </item>
        <item>
            <title>Is the Gene Patenting Party Over? Biotechnology Patents After In re Kubin</title>
            <link>http://www.medworm.com/index.php?rid=2661656&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9951%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 329-331. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661656</comments>
            <pubDate>Sat, 01 Aug 2009 16:15:34 +0100</pubDate>
            <guid isPermaLink="false">2661656</guid>        </item>
        <item>
            <title>Revisions to Regulations on Importation, Movement, and Release of Genetically Engineered Organisms</title>
            <link>http://www.medworm.com/index.php?rid=2661661&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9941%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 344-344. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661661</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:36 +0100</pubDate>
            <guid isPermaLink="false">2661661</guid>        </item>
        <item>
            <title>GAO Finds Serious Problems with Oversight of Clinical Trials; Draft Guidance on Cell Therapy for Heart Disease; Texas May Require Insurance Coverage of Routine Medical Care for Patients; in Clinical Trials; Hsp90 Inhibitor to Begin Phase I Study; Phase I Trial of Lung Cancer Drug Expanded</title>
            <link>http://www.medworm.com/index.php?rid=2661660&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9942%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 342-343. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661660</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:36 +0100</pubDate>
            <guid isPermaLink="false">2661660</guid>        </item>
        <item>
            <title>Secretary's Advisory Committee on Genetics, Health, and Society—Public Consultation Draft Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests (Draft Report for Public Comment) [excerpts]</title>
            <link>http://www.medworm.com/index.php?rid=2661673&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9956%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 417-442. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661673</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:35 +0100</pubDate>
            <guid isPermaLink="false">2661673</guid>        </item>
        <item>
            <title>Failure-to-Warn Prempro Case to Proceed; Class Action Status Denied in Vioxx Case</title>
            <link>http://www.medworm.com/index.php?rid=2661662&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9940%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 345-345. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661662</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:35 +0100</pubDate>
            <guid isPermaLink="false">2661662</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=2661677&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9938%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 478-481. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661677</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:34 +0100</pubDate>
            <guid isPermaLink="false">2661677</guid>        </item>
        <item>
            <title>CAFC Agrees Kubin Claims Are Obvious; Mixed Decision from CAFC on Changes Desired by PTO; Options for Patenting Genetic Tests; Roche Sues Mylan over Capecitabine Plans; Human Gene Patents Not as Toxic as Predicted; Pacific Biosciences Named Senior Party in Dispute with Life Technologies; Novocell Receives U.S. Endoderm Patent; Helicos to Appeal EPO Maintenance of Illumina Patent; Alnylam to Receive RNA Interference Patent; Mixed Decision in Compact Disk Dispute at ITC; Patent Misuse Defense Is One Issue</title>
            <link>http://www.medworm.com/index.php?rid=2661663&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9939%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 346-358. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661663</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:34 +0100</pubDate>
            <guid isPermaLink="false">2661663</guid>        </item>
        <item>
            <title>Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc. (2009-1071)</title>
            <link>http://www.medworm.com/index.php?rid=2661675&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9954%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 462-467. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661675</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:33 +0100</pubDate>
            <guid isPermaLink="false">2661675</guid>        </item>
        <item>
            <title>In re Marek Z. Kubin and Raymond G. Goodwin (2008-1184) (Serial no. 09/667,859)</title>
            <link>http://www.medworm.com/index.php?rid=2661672&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9957%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 409-416. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661672</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:33 +0100</pubDate>
            <guid isPermaLink="false">2661672</guid>        </item>
        <item>
            <title>Triantafyllos Tafas and SmithKline Beecham Corporation (doing business as GlaxoSmithKline), SmithKline Beecham PLC, and Glaxo Group Limited (doing business as GlaxoSmithKline) v. John J. Doll (2008-1352)</title>
            <link>http://www.medworm.com/index.php?rid=2661674&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9955%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 443-461. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661674</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:32 +0100</pubDate>
            <guid isPermaLink="false">2661674</guid>        </item>
        <item>
            <title>Importation, Interstate Movement, and Release into the Environment of Certain Genetically Engineered Organisms [excerpts]</title>
            <link>http://www.medworm.com/index.php?rid=2661671&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9958%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 382-408. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661671</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:32 +0100</pubDate>
            <guid isPermaLink="false">2661671</guid>        </item>
        <item>
            <title>2009 Draft Guidelines on Human Stem Cell Research</title>
            <link>http://www.medworm.com/index.php?rid=2661670&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9959%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 378-381. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661670</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:31 +0100</pubDate>
            <guid isPermaLink="false">2661670</guid>        </item>
        <item>
            <title>Lilly Entitled to Longer Protection of Raloxifene; Netherlands Removes Partial Patent Validity Law; Sanctionable Conduct Does Not Always Justify Award of Attorney Fees; Invitrogen–GE Healthcare Suit Sent to Texas; CAFC Rejects Appeal in HPV Case; Ariad, MIT Patent on Transcription Factor Fails Written Description Test; Motion for Summary Judgment of Non-Infringement Denied</title>
            <link>http://www.medworm.com/index.php?rid=2661664&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9950%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 359-365. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661664</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:30 +0100</pubDate>
            <guid isPermaLink="false">2661664</guid>        </item>
        <item>
            <title>Ariad Pharmaceuticals, Inc., Massachusetts Institute of Technology, The Whitehead Institute for Biomedical Research, and The President and Fellows of Harvard College v. Eli Lilly and Company (2008-1248)</title>
            <link>http://www.medworm.com/index.php?rid=2661676&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9953%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 468-477. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661676</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:29 +0100</pubDate>
            <guid isPermaLink="false">2661676</guid>        </item>
        <item>
            <title>The EPO's Decision G 2/06 on the Patentability of Human Embryonic Stem Cells: Sounding the Bell for the Next Round?</title>
            <link>http://www.medworm.com/index.php?rid=2661657&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9952%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 332-337. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661657</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:29 +0100</pubDate>
            <guid isPermaLink="false">2661657</guid>        </item>
        <item>
            <title>Obama Lays Out Procedures for Improving Scientific Integrity; Weill Medical College Fined over Inadequate Reporting of Scientist Workload; Former Bristol-Myers Executive Admits Attempting to Block Introduction of Generic Clopidogrel; Quest Diagnostics Settles over Diagnostic Kits; “Fake” Orthopedics Journal Revealed; Study Reporting Value of Bone Growth Protein Retracted</title>
            <link>http://www.medworm.com/index.php?rid=2661667&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9947%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 372-373. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661667</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:28 +0100</pubDate>
            <guid isPermaLink="false">2661667</guid>        </item>
        <item>
            <title>Research on Human Embryonic Stem Cells Now Eligible for NIH Funding; Tort Reform Legislation Proposed in Georgia; Free Access Policy Made Permanent; Worries About Synthetic Bioweapons; Two Animal Rights Extremists Indicted; Two Genetic Tests Not Endorsed by CDC Group; What Regulation Is Needed for Genetic Testing?; Possible Criminalization of Stem Cell Research</title>
            <link>http://www.medworm.com/index.php?rid=2661666&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9948%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 368-371. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661666</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:28 +0100</pubDate>
            <guid isPermaLink="false">2661666</guid>        </item>
        <item>
            <title>Medicare Considering Whether to Pay for Genetic Tests; Gifts and Consulting Fees Being Curtailed</title>
            <link>http://www.medworm.com/index.php?rid=2661665&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9949%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 366-367. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661665</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:27 +0100</pubDate>
            <guid isPermaLink="false">2661665</guid>        </item>
        <item>
            <title>Recombinant Drug May Be Rationed; Ranbaxy Still in Trouble with FDA; FDA Joins Nanotechnology Review Body; New HPV Tests Approved; FDA Official Reminds Staff to Protect Information; Anti-IL-6 Drug Linked to Deaths; Genentech Withdraws Raptiva Monoclonal Antibody; FDA Finds Problems with Internet Drug Advertisements</title>
            <link>http://www.medworm.com/index.php?rid=2661659&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9943%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 339-341. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661659</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:27 +0100</pubDate>
            <guid isPermaLink="false">2661659</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=2661669&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9945%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 377-377. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661669</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:26 +0100</pubDate>
            <guid isPermaLink="false">2661669</guid>        </item>
        <item>
            <title>In re Gleave: Anticipation of Genus by Prior Art Species in Long List</title>
            <link>http://www.medworm.com/index.php?rid=2661658&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9944%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 338-338. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661658</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:26 +0100</pubDate>
            <guid isPermaLink="false">2661658</guid>        </item>
        <item>
            <title>Bibliography</title>
            <link>http://www.medworm.com/index.php?rid=2661668&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9946%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Jun 2009, Vol. 28, No. 3: 374-376. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661668</comments>
            <pubDate>Sat, 01 Aug 2009 16:06:24 +0100</pubDate>
            <guid isPermaLink="false">2661668</guid>        </item>
        <item>
            <title>The Industrial Applicability of Biotechnology Patents—A New Test for Europe</title>
            <link>http://www.medworm.com/index.php?rid=2419687&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9972%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 151-158. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419687</comments>
            <pubDate>Fri, 15 May 2009 11:27:17 +0100</pubDate>
            <guid isPermaLink="false">2419687</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=2419710&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9960%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 323-327. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419710</comments>
            <pubDate>Fri, 15 May 2009 11:05:39 +0100</pubDate>
            <guid isPermaLink="false">2419710</guid>        </item>
        <item>
            <title>Pfizer Said to Be Guilty of Trade Secret Violations; NEJM Revises Disclosure Rules; Harvard Reviews Conflict of Interest Rules Again; PhRMA Bans Gifts; Massachusetts Biotechnology Chief Faces $10,000 Ethics Fine; Japanese Postdoc May Have Been Guilty of Misconduct</title>
            <link>http://www.medworm.com/index.php?rid=2419697&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9963%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 189-190. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419697</comments>
            <pubDate>Fri, 15 May 2009 11:05:38 +0100</pubDate>
            <guid isPermaLink="false">2419697</guid>        </item>
        <item>
            <title>Some Scientists Concerned About Dual-Use Research; Animal Rights Activists Convicted of Blackmail, Terroristic Threats; Paper Removed for Possible Defamation; Are Restrictions on Industry Ties to Physicians Costing Boston Money?</title>
            <link>http://www.medworm.com/index.php?rid=2419696&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9964%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 187-188. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419696</comments>
            <pubDate>Fri, 15 May 2009 11:05:38 +0100</pubDate>
            <guid isPermaLink="false">2419696</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=2419699&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9961%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 195-196. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419699</comments>
            <pubDate>Fri, 15 May 2009 11:05:37 +0100</pubDate>
            <guid isPermaLink="false">2419699</guid>        </item>
        <item>
            <title>Bibliography</title>
            <link>http://www.medworm.com/index.php?rid=2419698&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9962%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 191-194. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419698</comments>
            <pubDate>Fri, 15 May 2009 11:05:37 +0100</pubDate>
            <guid isPermaLink="false">2419698</guid>        </item>
        <item>
            <title>Guidance for Industry: Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs</title>
            <link>http://www.medworm.com/index.php?rid=2419701&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9978%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 227-240. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419701</comments>
            <pubDate>Fri, 15 May 2009 11:05:36 +0100</pubDate>
            <guid isPermaLink="false">2419701</guid>        </item>
        <item>
            <title>Wyeth v. Diana Levine (No. 06-1249)</title>
            <link>http://www.medworm.com/index.php?rid=2419700&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9979%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 197-226. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419700</comments>
            <pubDate>Fri, 15 May 2009 11:05:36 +0100</pubDate>
            <guid isPermaLink="false">2419700</guid>        </item>
        <item>
            <title>Guidance for Industry: Evidence-Based Review System for the Scientific Evaluation of Health Claims</title>
            <link>http://www.medworm.com/index.php?rid=2419702&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9977%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 241-258. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419702</comments>
            <pubDate>Fri, 15 May 2009 11:05:35 +0100</pubDate>
            <guid isPermaLink="false">2419702</guid>        </item>
        <item>
            <title>The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information</title>
            <link>http://www.medworm.com/index.php?rid=2419703&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9976%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 259-276. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419703</comments>
            <pubDate>Fri, 15 May 2009 11:05:34 +0100</pubDate>
            <guid isPermaLink="false">2419703</guid>        </item>
        <item>
            <title>Juries Trump FDA in Writing Drug Labels; FDA Grants Clinical Trial Permission for Human Embryonic Stem Cells; Alerts Issued for Two Biotechnology Products; Japanese Rheumatoid Arthritis Drug Approved in Europe; FDA Criticizes Humira Ad; Amgen's BLA for Bone Drug Accepted; Rules for Claiming Health Benefits from Food and Supplements</title>
            <link>http://www.medworm.com/index.php?rid=2419689&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9971%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 159-164. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419689</comments>
            <pubDate>Fri, 15 May 2009 11:05:34 +0100</pubDate>
            <guid isPermaLink="false">2419689</guid>        </item>
        <item>
            <title>Kaiser Foundation Health Plan Inc. v. Abbott Laboratories, Inc.; Geneva Pharmaceuticals Technology Corporation (No. 06-55687, D.C. No. CV-02-02443-JFW; No. 06-55748, D.C. No. CV-02-02443-JFW)</title>
            <link>http://www.medworm.com/index.php?rid=2419709&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9973%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 309-322. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419709</comments>
            <pubDate>Fri, 15 May 2009 11:05:33 +0100</pubDate>
            <guid isPermaLink="false">2419709</guid>        </item>
        <item>
            <title>Deficits Found in Review of Financial Conflicts of Interest for Clinical Investigators</title>
            <link>http://www.medworm.com/index.php?rid=2419690&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9970%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 165-166. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419690</comments>
            <pubDate>Fri, 15 May 2009 11:05:33 +0100</pubDate>
            <guid isPermaLink="false">2419690</guid>        </item>
        <item>
            <title>Bert W. Rein; Hunton &amp; Williams v. United States Patent &amp; Trademark Office (No. 07-1738)</title>
            <link>http://www.medworm.com/index.php?rid=2419705&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9975%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 277-292. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419705</comments>
            <pubDate>Fri, 15 May 2009 11:05:32 +0100</pubDate>
            <guid isPermaLink="false">2419705</guid>        </item>
        <item>
            <title>In Re: Hydrogen Peroxide Antitrust Litigation (No. 07-1689)</title>
            <link>http://www.medworm.com/index.php?rid=2419707&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9974%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 293-308. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419707</comments>
            <pubDate>Fri, 15 May 2009 11:05:31 +0100</pubDate>
            <guid isPermaLink="false">2419707</guid>        </item>
        <item>
            <title>Human–Animal Embryo Chimeras Fail; Vaccines Do Not Cause Autism; Potatoes Being Genetically Modified to Resist Blight; Gene Therapy May Be Useful Against HIV; Cell Therapy for Fractures?; Improving Radiosensitivity of Cancer; Rheumatoid Arthritis Patients Benefit from Gene Therapy; Fetal Stem Cell Therapy Leads to Tumors; Possible Nanotechnology Utility for Glucose Monitoring</title>
            <link>http://www.medworm.com/index.php?rid=2419695&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9965%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 183-186. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419695</comments>
            <pubDate>Fri, 15 May 2009 11:05:30 +0100</pubDate>
            <guid isPermaLink="false">2419695</guid>        </item>
        <item>
            <title>New Standard for Certifying Class Status; Mixed Decision in Antitrust Suit Involving Terazosin</title>
            <link>http://www.medworm.com/index.php?rid=2419694&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9966%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 179-182. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419694</comments>
            <pubDate>Fri, 15 May 2009 11:05:30 +0100</pubDate>
            <guid isPermaLink="false">2419694</guid>        </item>
        <item>
            <title>ABI Is Not Infringing Illumina Patent; Qiagen and ABI Settle on Thermal Cyclers; Abbott Accused of Infringing Antibody Patent</title>
            <link>http://www.medworm.com/index.php?rid=2419693&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9967%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 177-178. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419693</comments>
            <pubDate>Fri, 15 May 2009 11:05:29 +0100</pubDate>
            <guid isPermaLink="false">2419693</guid>        </item>
        <item>
            <title>What Does a Vaughn Index Require?; Update on In re Kubin; Cabilly II Patent Reinstated; Advaxis Retains European Cancer Vaccine Patent; Fetal Stem Cell Patent Issued to Neuralstem; Press Clippings</title>
            <link>http://www.medworm.com/index.php?rid=2419692&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9968%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 173-176. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419692</comments>
            <pubDate>Fri, 15 May 2009 11:05:29 +0100</pubDate>
            <guid isPermaLink="false">2419692</guid>        </item>
        <item>
            <title>Revised Guidance on Genetically Engineered Animals; First “Biopharm” Product Approved by FDA; House Introduces Bill on Safety of Nanotechnology; Cloned Animals Safe to Eat, Japan Finds; Europe Still Debating Safety of Genetically Modified Plants; Risk to U.S. Food Supply from Foreign Genetically Engineered Crops Seen; Update on Dissemination of Genetically Engineered Crops</title>
            <link>http://www.medworm.com/index.php?rid=2419691&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9969%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Apr 2009, Vol. 28, No. 2: 167-172. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419691</comments>
            <pubDate>Fri, 15 May 2009 11:05:27 +0100</pubDate>
            <guid isPermaLink="false">2419691</guid>        </item>
        <item>
            <title>Getting Written Description Right in the Biotechnology Arts: A Realist Approach to Patent Scope</title>
            <link>http://www.medworm.com/index.php?rid=2310507&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9988%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 1-17. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310507</comments>
            <pubDate>Thu, 02 Apr 2009 17:26:39 +0100</pubDate>
            <guid isPermaLink="false">2310507</guid>        </item>
        <item>
            <title>Cotton Oil and Seed Contaminated with Unapproved Variety; Second-Generation Genetically Modified Soybean Approved for Use (But Not Planting) in Europe; NAS Committee Finds Inadequacies in Federal Nanotechnology Research and Regulation; Universal Waste Rules Now Cover Drugs</title>
            <link>http://www.medworm.com/index.php?rid=2310510&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9985%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 23-25. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310510</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:23 +0100</pubDate>
            <guid isPermaLink="false">2310510</guid>        </item>
        <item>
            <title>Data Must Be Retained When Subjects Withdraw from a Trial; When Should Antineoplastic Drug Use Be Restricted by Genetics?; FibroGen Drug for Pancreatic Cancer Begins Trials; Stem Cell Trial in Ischemic Stroke Begins</title>
            <link>http://www.medworm.com/index.php?rid=2310509&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9986%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 21-22. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310509</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:22 +0100</pubDate>
            <guid isPermaLink="false">2310509</guid>        </item>
        <item>
            <title>CAFC Split on Abbott-Sandoz Litigation; A Patent on a Racemate Does Not Preclude One on an Enantiomer; CAFC Upholds Attorney, Expert Witness Fees; eBioscience Says It Is Not Infringing Invitrogen Patents; One Boniva Patent Found Invalid</title>
            <link>http://www.medworm.com/index.php?rid=2310512&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9983%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 33-38. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310512</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:20 +0100</pubDate>
            <guid isPermaLink="false">2310512</guid>        </item>
        <item>
            <title>Thomson Patent Fails in Europe; CAFC Considers Grouping of Claims; University Petitions for Addition of Inventors; Myriad Gets Its European BRCA Patent Back, But with Modifications; One Antibody Does Not Characterize a Class; FDA Has Advice on Patents for “Old” Antibiotics; Nutraceutical Juice Is Obvious</title>
            <link>http://www.medworm.com/index.php?rid=2310511&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9984%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 26-32. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310511</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:18 +0100</pubDate>
            <guid isPermaLink="false">2310511</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=2310514&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9981%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 41-42. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310514</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:17 +0100</pubDate>
            <guid isPermaLink="false">2310514</guid>        </item>
        <item>
            <title>Vatican Issues Authoritative Statement on Reproductive Science; Concern About Web Ads for Stem Cell Therapy; U.K. Government Authorizes Hybrid Embryos for Stem Cell Research</title>
            <link>http://www.medworm.com/index.php?rid=2310513&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9982%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 39-40. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310513</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:15 +0100</pubDate>
            <guid isPermaLink="false">2310513</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=2310526&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9980%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 147-150. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310526</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:11 +0100</pubDate>
            <guid isPermaLink="false">2310526</guid>        </item>
        <item>
            <title>Guidance for Sponsors, Clinical Investigators, and IRBs: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=2310515&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9999%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 43-46. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310515</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:08 +0100</pubDate>
            <guid isPermaLink="false">2310515</guid>        </item>
        <item>
            <title>Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics</title>
            <link>http://www.medworm.com/index.php?rid=2310516&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9998%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 47-55. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310516</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:05 +0100</pubDate>
            <guid isPermaLink="false">2310516</guid>        </item>
        <item>
            <title>In re Kenneth Alonso</title>
            <link>http://www.medworm.com/index.php?rid=2310520&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9994%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 83-87. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310520</comments>
            <pubDate>Thu, 02 Apr 2009 17:22:03 +0100</pubDate>
            <guid isPermaLink="false">2310520</guid>        </item>
        <item>
            <title>University of Kansas Center for Research, Inc. v. The United States of America, Represented by the Department of Health and Human Services, by and Through Its Agents the National Institutes of Health and the National Cancer Institute</title>
            <link>http://www.medworm.com/index.php?rid=2310519&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9995%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 79-82. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310519</comments>
            <pubDate>Thu, 02 Apr 2009 17:21:51 +0100</pubDate>
            <guid isPermaLink="false">2310519</guid>        </item>
        <item>
            <title>Guidance for Industry: Submission of Patent Information for Certain Old Antibiotics</title>
            <link>http://www.medworm.com/index.php?rid=2310518&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9996%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 76-78. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310518</comments>
            <pubDate>Thu, 02 Apr 2009 17:21:32 +0100</pubDate>
            <guid isPermaLink="false">2310518</guid>        </item>
        <item>
            <title>Amendment to the Universal Waste Rule: Addition of Pharmaceuticals [excerpts]</title>
            <link>http://www.medworm.com/index.php?rid=2310517&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9997%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 56-75. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310517</comments>
            <pubDate>Thu, 02 Apr 2009 17:21:01 +0100</pubDate>
            <guid isPermaLink="false">2310517</guid>        </item>
        <item>
            <title>Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. and Apotex Corp</title>
            <link>http://www.medworm.com/index.php?rid=2310524&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9990%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 129-138. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310524</comments>
            <pubDate>Thu, 02 Apr 2009 17:20:37 +0100</pubDate>
            <guid isPermaLink="false">2310524</guid>        </item>
        <item>
            <title>Abbott Laboratories v. Sandoz, Inc</title>
            <link>http://www.medworm.com/index.php?rid=2310523&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9991%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 101-128. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310523</comments>
            <pubDate>Thu, 02 Apr 2009 17:20:33 +0100</pubDate>
            <guid isPermaLink="false">2310523</guid>        </item>
        <item>
            <title>Gilbert P. Hyatt v. Jon W. Dudas</title>
            <link>http://www.medworm.com/index.php?rid=2310522&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9992%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 96-100. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310522</comments>
            <pubDate>Thu, 02 Apr 2009 17:19:56 +0100</pubDate>
            <guid isPermaLink="false">2310522</guid>        </item>
        <item>
            <title>In re DBC</title>
            <link>http://www.medworm.com/index.php?rid=2310521&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9993%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 88-95. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310521</comments>
            <pubDate>Thu, 02 Apr 2009 17:19:43 +0100</pubDate>
            <guid isPermaLink="false">2310521</guid>        </item>
        <item>
            <title>FDA Issues Guidance on Cooperative Manufacturing; Another Hold-Up for Rheumatoid Arthritis Drug; FDA, WebMD Launch Website; Grassley Wants More Information on Ghostwritten Articles on Hormone Replacement Product; Genentech Petitions for Tighter Regulation of Laboratory Tests; FDA Delays Decision on Myozyme; Recent Approvals</title>
            <link>http://www.medworm.com/index.php?rid=2310508&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9987%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 18-20. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310508</comments>
            <pubDate>Thu, 02 Apr 2009 17:19:40 +0100</pubDate>
            <guid isPermaLink="false">2310508</guid>        </item>
        <item>
            <title>Takeda Chemical Industries, Ltd. and Takeda Pharmaceuticals North America, Inc. v. Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc., and Alphapharm Pty., Ltd. and Genpharm, Inc</title>
            <link>http://www.medworm.com/index.php?rid=2310525&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2009.9989%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Feb 2009, Vol. 28, No. 1: 139-146. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2310525</comments>
            <pubDate>Thu, 02 Apr 2009 17:19:05 +0100</pubDate>
            <guid isPermaLink="false">2310525</guid>        </item>
        <item>
            <title>FASB Proposal Protested; Monsanto Sells Bovine Hormone Franchise; Parallel Drug Distributors May Lose to Counterfeit Prevention Rules</title>
            <link>http://www.medworm.com/index.php?rid=2136118&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9895%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 561-562. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2136118</comments>
            <pubDate>Wed, 28 Jan 2009 03:31:49 +0100</pubDate>
            <guid isPermaLink="false">2136118</guid>        </item>
        <item>
            <title>Intellectual Property Protection of Plant Varieties in Asian Developing Countries</title>
            <link>http://www.medworm.com/index.php?rid=2127107&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9903%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 525-531. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127107</comments>
            <pubDate>Fri, 23 Jan 2009 17:27:34 +0100</pubDate>
            <guid isPermaLink="false">2127107</guid>        </item>
        <item>
            <title>Draft Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products</title>
            <link>http://www.medworm.com/index.php?rid=2127119&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9910%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 568-577. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127119</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:39 +0100</pubDate>
            <guid isPermaLink="false">2127119</guid>        </item>
        <item>
            <title>On the Move</title>
            <link>http://www.medworm.com/index.php?rid=2127118&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9892%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 566-567. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127118</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:38 +0100</pubDate>
            <guid isPermaLink="false">2127118</guid>        </item>
        <item>
            <title>Embryos Will Still Be Necessary; Do Bt Crops Protect Other Plants?; Rules Promulgated for Racial Identification; Nanotechnology Imaging Technique Tested</title>
            <link>http://www.medworm.com/index.php?rid=2127117&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9893%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 564-565. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127117</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:37 +0100</pubDate>
            <guid isPermaLink="false">2127117</guid>        </item>
        <item>
            <title>Coming Events</title>
            <link>http://www.medworm.com/index.php?rid=2127126&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9891%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 623-626. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127126</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:36 +0100</pubDate>
            <guid isPermaLink="false">2127126</guid>        </item>
        <item>
            <title>Is This License Still in Effect?; Invitrogen Accuses Vanderbilt, Oxford of License Violation</title>
            <link>http://www.medworm.com/index.php?rid=2127114&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9896%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 558-560. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127114</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:34 +0100</pubDate>
            <guid isPermaLink="false">2127114</guid>        </item>
        <item>
            <title>Roche Is Not Infringing Carnegie Mellon Patents Disclosing Method of Producing Enzyme; Amgen Wins Permanent Injunction Blocking Sales of Competing Epo Formulation; Co-op Concedes It Is Violating Monsanto Patents; CAFC Agrees Claims for Declaratory Judgment of Noninfringement Should Have Been Dismissed; Patent on Treatment of ALS with Riluzole Not Anticipated; BLR Archives: Pfizer Loses One Patent for Double Patenting But Keeps Two More; §121 Protection Applies Only to Divisional Applications; Colliding Generic Companies; University of Iowa Sues Amgen for Infringement</title>
            <link>http://www.medworm.com/index.php?rid=2127113&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9897%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 550-557. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127113</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:33 +0100</pubDate>
            <guid isPermaLink="false">2127113</guid>        </item>
        <item>
            <title>Falsified Data, But No Misconduct; FBI Says One Person Solely Responsible for Anthrax Attacks</title>
            <link>http://www.medworm.com/index.php?rid=2127116&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9894%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 563-563. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127116</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:32 +0100</pubDate>
            <guid isPermaLink="false">2127116</guid>        </item>
        <item>
            <title>FASB Proposal Protested; Monsanto Sells Bovine Hormone Franchise Parallel Drug Distributors May Lose to Counterfeit Prevention Rules</title>
            <link>http://www.medworm.com/index.php?rid=2127115&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9895%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 561-562. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127115</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:30 +0100</pubDate>
            <guid isPermaLink="false">2127115</guid>        </item>
        <item>
            <title>Regulations on Genetically Engineered Animals; Publications from FDA, APHIS Released; Recombinant Rabies Vaccine to Be Tested; Herbicide-Tolerant Soybeans Deregulated; G8 Nations Want Greater Use of Genetically Engineered Plants; France May Be Fined over Laws on Genetically Engineered Crops; Concern About Nanotechnology Effects on Bacteria</title>
            <link>http://www.medworm.com/index.php?rid=2127111&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9899%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 541-542. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127111</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:29 +0100</pubDate>
            <guid isPermaLink="false">2127111</guid>        </item>
        <item>
            <title>Findings of Fact and Conclusions of Law: University of Pittsburg of the Commonwealth System of Higher Education v. Marc H. Hedrick, Prosper Benhaim, Hermann Peter Lorenz, and Min Zhu (No. CV04-9014 CBM [AJWx])</title>
            <link>http://www.medworm.com/index.php?rid=2127121&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9908%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 580-587. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127121</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:27 +0100</pubDate>
            <guid isPermaLink="false">2127121</guid>        </item>
        <item>
            <title>Present Intellectual Property System May Be Hampering Medicine and Biological Sciences; Four Inventors Removed from Patent on Stem Cells from Adipose Tissue; CAFC Agrees Analytical Technique Patent Is Obvious; Genetic Technologies Corrects False Press Reports; BLR Archives: You Have to Pay the Fees; EPO Rejects RNAi Patent</title>
            <link>http://www.medworm.com/index.php?rid=2127112&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9898%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 543-549. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127112</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:27 +0100</pubDate>
            <guid isPermaLink="false">2127112</guid>        </item>
        <item>
            <title>FR Doc E8-21977: Animal and Plant Health Inspection Service: Genetically Engineered Animals</title>
            <link>http://www.medworm.com/index.php?rid=2127120&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9909%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 578-579. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127120</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:25 +0100</pubDate>
            <guid isPermaLink="false">2127120</guid>        </item>
        <item>
            <title>Carnegie Mellon University v. Hoffmann-La Roche Inc., Roche Molecular Systems, Inc., Roche Diagnostics Corporation, Laboratory Corporation of America, and Applera Corporation (2007-1267)</title>
            <link>http://www.medworm.com/index.php?rid=2127123&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9906%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 597-606. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127123</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:24 +0100</pubDate>
            <guid isPermaLink="false">2127123</guid>        </item>
        <item>
            <title>In re Melvin J. Swanson and Patrick E. Guire (Reexamination No. 90/006,785)</title>
            <link>http://www.medworm.com/index.php?rid=2127122&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9907%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 588-596. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127122</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:23 +0100</pubDate>
            <guid isPermaLink="false">2127122</guid>        </item>
        <item>
            <title>Janssen Pharmaceutica, N.V. and Janssen, L.P. v. Apotex, Inc. (2008-1062)</title>
            <link>http://www.medworm.com/index.php?rid=2127125&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9904%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 616-622. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127125</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:22 +0100</pubDate>
            <guid isPermaLink="false">2127125</guid>        </item>
        <item>
            <title>Pfizer, Inc., Pharmacia Corp., Pharmacia &amp; Upjohn, Inc., Pharmacia &amp; Upjohn Company, G.D. Searle &amp; Co., G.D. Searle LLC, Searle LLC (Delaware), and Searle LLC (Nevada) v. Teva Pharmaceuticals USA, Inc. (2007-1271)</title>
            <link>http://www.medworm.com/index.php?rid=2127124&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9905%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 607-615. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127124</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:22 +0100</pubDate>
            <guid isPermaLink="false">2127124</guid>        </item>
        <item>
            <title>The Olanzapine Patent Dispute: German Court Grants a Preliminary Injunction on a Patent Invalidated by the First-Instance Federal Patent Court</title>
            <link>http://www.medworm.com/index.php?rid=2127108&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9902%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 532-536. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127108</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:20 +0100</pubDate>
            <guid isPermaLink="false">2127108</guid>        </item>
        <item>
            <title>Negative Clinical Trial Results Less Likely to Be Published; Pfizer Said to Have Hidden Negative Trial Results</title>
            <link>http://www.medworm.com/index.php?rid=2127110&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9900%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 540-540. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127110</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:17 +0100</pubDate>
            <guid isPermaLink="false">2127110</guid>        </item>
        <item>
            <title>Australia Allows Human Embryo Cloning; One-Stop Shop for Drug Safety Information; Ranbaxy Can Ship Drugs to U.S. from All Plants; Guidance on Potency of Cell and Gene Therapeutics; Cepheid Gets Clearance for Fast MRSA Test</title>
            <link>http://www.medworm.com/index.php?rid=2127109&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9901%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Dec 2008, Vol. 27, No. 6: 537-539. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2127109</comments>
            <pubDate>Fri, 23 Jan 2009 17:15:15 +0100</pubDate>
            <guid isPermaLink="false">2127109</guid>        </item>
        <item>
            <title>Challenges for Biotechnology Law</title>
            <link>http://www.medworm.com/index.php?rid=1978138&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9920%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 421-424. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978138</comments>
            <pubDate>Wed, 19 Nov 2008 15:59:43 +0100</pubDate>
            <guid isPermaLink="false">1978138</guid>        </item>
        <item>
            <title>Class Action for Rice Contamination Suit Denied; Bt Vip3Aa Proteins Exempted; Free Speech Permits Use of Inaccurate Term; USDA Analyzes Traceability and Labeling Requirements</title>
            <link>http://www.medworm.com/index.php?rid=1978141&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9917%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 435-436. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978141</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:45 +0100</pubDate>
            <guid isPermaLink="false">1978141</guid>        </item>
        <item>
            <title>Company Ordered to Admit Patient to Trial; Company Shows Bioequivalence of Possible Follow-On Biologic</title>
            <link>http://www.medworm.com/index.php?rid=1978140&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9918%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 434-434. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978140</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:45 +0100</pubDate>
            <guid isPermaLink="false">1978140</guid>        </item>
        <item>
            <title>FDA Seeks Quality Information; Legislative Filings to Overturn Preemption Decisions; Supreme Court Prepares To Hear Wyeth v. Levine; Generic Drug Company Runs Afoul of FDA; Approvable, Not Approvable System Being Replaced; New Guidance on Advisory Committees; GMPs No Longer Required for Phase I Biologics; Security to Be Improved at Advisory Committee Meetings; FDA Recommends Genetic Test Before Drug Use; Stronger Warning for TNF-Alpha Blockers; Changes Coming in Post-Approval Review No More “Throw the Drug over the Wall” and Wait; More Labeling Revisions for Tysabri, Epo; Information on Expensive Drugs Being Withheld; Patients Given Right to Be Told About Clinical Trials; Countries to Collaborate on Drug Facility Inspections; California Tries to Halt DTC Genetic Test Sales; PhRMA Revises Marketing Recommendations; Transplant Tourism Decried; Stanford Restricts Use of Drug Company Money for Medical Education; Labeling for Hormone Replacement Therapy Found Adequate</title>
            <link>http://www.medworm.com/index.php?rid=1978139&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9919%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 425-433. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978139</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:45 +0100</pubDate>
            <guid isPermaLink="false">1978139</guid>        </item>
        <item>
            <title>BLR Update: “Serious Problems” Identified in Stem Cell Trial; Researcher Does Not Disclose Patent in Paper; Payment from Sponsor Was Reported; Patent Disclosed to NIH and FDA</title>
            <link>http://www.medworm.com/index.php?rid=1978145&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9913%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 442-442. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978145</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:44 +0100</pubDate>
            <guid isPermaLink="false">1978145</guid>        </item>
        <item>
            <title>EC Pursues Parallel Trade; Scientist Wants Royalties; Selden to Pay SEC Fine</title>
            <link>http://www.medworm.com/index.php?rid=1978144&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9914%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 441-441. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978144</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:44 +0100</pubDate>
            <guid isPermaLink="false">1978144</guid>        </item>
        <item>
            <title>Stanford's Patents for HIV Monitoring Are Obvious; NP Test Said to Infringe; MIT Sues Affymetrix over GeneChip Products</title>
            <link>http://www.medworm.com/index.php?rid=1978143&amp;cid=s_30979_24_f&amp;fid=30979&amp;url=http%3A%2F%2Fwww.liebertonline.com%2Fdoi%2Fabs%2F10.1089%2Fblr.2008.9915%3Fai%3Dsi%26mi%3Do0fy%26af%3DR</link>
            <description>Biotechnology Law Report Oct 2008, Vol. 27, No. 5: 438-440. (Source: Biotechnology Law Report)</description>
            <author>Biotechnology Law Report</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1978143</comments>
            <pubDate>Wed, 19 Nov 2008 15:49:44 +0100</pubDate>
            <guid isPermaLink="false">1978143</guid>        </item>
    </channel>
</rss>
